Stifel Reiterates Buy Rating on Contineum Therapeutics (CTNM) Mar 5, 2026 05:47PM
Contineum Therapeutics, Inc. (CTNM) Tops Q4 EPS by 16c Mar 5, 2026 04:09PM
Morgan Stanley Downgrades Contineum Therapeutics (CTNM) to Equalweight Jan 8, 2026 03:39AM
Stifel Reiterates Buy Rating on Contineum Therapeutics (CTNM) Nov 21, 2025 08:59AM
After-hours movers: Ross Stores, GAP, Intuit and more Nov 20, 2025 04:34PM


Oct 14, 2025 06:14AM RBC Capital Reiterates Outperform Rating on Contineum Therapeutics (CTNM)
Sep 25, 2025 06:19AM Leerink Partners Starts Contineum Therapeutics (CTNM) at Outperform
Aug 6, 2025 03:51PM Contineum Therapeutics, Inc. (CTNM) Misses Q2 EPS by 34c
Jun 25, 2025 08:15AM Contineum Therapeutics (CTNM) Provides Update on Phase 1b Positron Emission Tomography Trial of PIPE-791
Jun 18, 2025 04:11PM William Blair Starts Contineum Therapeutics (CTNM) at Outperform
May 15, 2025 05:28PM Contineum Therapeutics, Inc. (CTNM) Misses Q1 EPS by 20c
May 14, 2025 04:43PM Contineum Therapeutics (CTNM) Files $300M Mixed Shelf
Mar 17, 2025 04:05PM Contineum Therapeutics (CTNM) Appoints Diego Miralles to its Board
Mar 7, 2025 06:18AM Contineum Therapeutics, Inc. (CTNM) Misses Q4 EPS by 11c
Dec 16, 2024 04:06PM Contineum Therapeutics (CTNM) Initiates Patient Dosing in Phase 1b Positron Emission Tomography (PET) Trial of PIPE-791
Nov 18, 2024 08:05AM Contineum Therapeutics (CTNM) Expands Clinical Development of PIPE-791
Oct 22, 2024 05:24AM Baird Starts Contineum Therapeutics (CTNM) at Outperform
Aug 15, 2024 07:46AM Stifel Reiterates Buy Rating on Contineum Therapeutics (CTNM)
Aug 14, 2024 03:39PM Contineum Therapeutics, Inc. (CTNM) Misses Q2 EPS by 3c
Aug 14, 2024 06:24AM Contineum Therapeutics (CTNM) PT Raised to $32 at RBC Capital